Alignment Healthcare, Inc. Common Stock(ALHC)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$20.46
After hours
$20.64
+0.19%
- 52-Week Range
- $11.62 – $23.87
- YTD
- +1.19%
- IV Rank (30D)
- 45.1
- Straddle Price
- $2.95
- P/C Vol Ratio
- 1.37
- Market Cap
- $4.1B
Fair Value
+15.0% vs price
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.45% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.95% (VRP-adj) |
| WACC | 9.67% |
| Volatility Risk Premium | +42.1pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 0.1% |
| Rev. Growth (YoY, DCF input) | +20.8% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | 9.6% |
| Book / Price | 5.0% |
| Gross Margin (TTM) | 11.4% |
| FCF Margin (TTM) | 5.4% |
| Debt / Equity | 1.56 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | +5.8% (reverse-DCF on current price) |
| SMA 50 | $18.64 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $16.58 |
| Bollinger Width / SMA20 | 307.7% (drives anchor stability) |
| Net Debt | $-0.4B |
| Market Cap | $4B |
Peers used for multiples: DXCM, GEHC, HIMS, ISRG, OSCR, PODD, PRVA, RMD
Blended Fair Value
$23.68
Current Price
$20.60
Deviation
+15.0%
Forward-Return Rank
LONG
gates ✓
?
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -3.8% ⚠ | -0.31 | -0.11 | 18.8% | — |
| 42d | -6.4% ⚠ | -0.43 | -0.17 | 16.7% | — |
| 63d | -5.7% ⚠ | -0.04 | +0.02 | 24.0% | — |
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon).
For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference.
⚠ flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $34.47 | 27% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $5.04 | 8% | median 32.8× · 6 peers |
| Peer EV/EBITDA | $3.86 | 8% | median 18.0× · 7 peers |
| Peer P/B | $6.52 | 8% | median 6.5× · 8 peers |
| Peer P/S | $69.13 | 8% | median 3.1× · 8 peers |
| Market Anchor (SMA50) | $18.64 | 41% | stability 77% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-06-16 · updated 2026-06-16 20:59:30.632000
Info
- Industry (SIC)
- HOSPITAL & MEDICAL SERVICE PLANS (6324)
- Exchange
- XNAS
- Market Cap
- $4.1B
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +0.16% | 5 |
| Feb | -8.01% | 5 |
| Mar | +5.52% | 6 |
| Apr | +5.20% | 6 |
| May | -3.07% | 6 |
| Jun | +3.68% | 6 |
| Jul | +5.54% | 5 |
| Aug | -4.34% | 5 |
| Sep | +5.09% | 5 |
| Oct | +6.86% | 5 |
| Nov | +1.38% | 5 |
| Dec | -2.29% | 5 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $16.80
SMA 50: $18.68
SMA 200: $18.65
Current: $20.60
EMA 12: $18.35
EMA 26: $17.78
MACD: 0.5678 | Signal: 0.7296
BEARISH
ADX (14): 32.83
TREND
+DI: 41.40
−DI: 24.05
Momentum Oscillators
RSI (14): 65.36
NEUTRAL
Stoch %K: 85.28
Stoch %D: 85.83
Williams %R: -7.93
Volume & Volatility
BB Upper: $21.37
BB Lower: $12.22
NEUTRAL
OBV: 38,871,457
Vol SMA 20: 6,370,907
Vol ROC: 3.97%
ATR: $1.12
True Range: $0.95
HV 20: 104.9%
HV 30: 97.2%
HV 60: 82.5%
Data Summary
Data Points: 500
Last Updated: 2026-06-16T21:15:07.450000
Date Range: 2024-06-18T00:00:00 – 2026-06-16T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
As a Medicare Advantage provider focused on tech-enabled care, this California-based firm reported a notable insider sale last week.
Earnings History
8 of 8 under expected move
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-01 | After-Close | 21.95% | 1.87% | 0.09x | Within |
| 2024-10-29 | After-Close | 23.88% | 4.64% | 0.19x | Within |
| 2025-02-27 | After-Close | 15.92% | 6.16% | 0.39x | Within |
| 2025-05-01 | After-Close | 15.86% | 8.16% | 0.51x | Within |
| 2025-07-30 | After-Close | 19.93% | 6.89% | 0.35x | Within |
| 2025-10-30 | After-Close | 11.76% | 8.86% | 0.75x | Within |
| 2026-02-26 | After-Close | 12.36% | 4.72% | 0.38x | Within |
| 2026-04-30 | After-Close | 14.10% | 7.87% | 0.56x | Within |
Options Activity
- IV Rank (30D)
- 45.1
- IV Rank (7D)
- 100
- Avg IV
- 134.4%
- Straddle (30D)
- $2.95
- Straddle (7D)
- $0.82
- P/C Volume
- 1.37
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 0.52
- Correlation (SPY)
- 11.6%
- R²
- 0.01
- Ann. Volatility
- 55.7%
- SPY Volatility
- 12.4%
Low volatility - stock moves less than market
Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
? 13F Guide
Diluted shares outstanding: 207,395,514 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
9 filers$24.02M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $11.28M | 46.95% | 2026-03-31 |
| 2 | CITADEL ADVISORS LLC Custodian | $6.44M | 26.81% | 2026-03-31 |
| 3 | MILLENNIUM MANAGEMENT LLC Custodian | $2.47M | 10.27% | 2026-03-31 |
| 4 | JANE STREET GROUP, LLC Custodian | $1.64M | 6.81% | 2026-03-31 |
| 5 | GROUP ONE TRADING LLC Custodian | $755.90K | 3.15% | 2026-03-31 |
| 6 | SIMPLEX TRADING, LLC Custodian | $627.27K | 2.61% | 2026-03-31 |
| 7 | IMC-Chicago, LLC Custodian | $444.02K | 1.85% | 2026-03-31 |
| 8 | HAP TRADING, LLC | $369.08K | 1.54% | 2025-09-30 |
| 9 | Walleye Capital LLC | $3.52K | 0.01% | 2026-03-31 |
7 filers$6.83M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $3.83M | 56.09% | 2026-03-31 |
| 2 | JANE STREET GROUP, LLC Custodian | $1.08M | 15.84% | 2026-03-31 |
| 3 | CITADEL ADVISORS LLC Custodian | $1.04M | 15.17% | 2026-03-31 |
| 4 | SIMPLEX TRADING, LLC Custodian | $514.50K | 7.53% | 2026-03-31 |
| 5 | IMC-Chicago, LLC Custodian | $186.77K | 2.73% | 2026-03-31 |
| 6 | Walleye Capital LLC | $112.77K | 1.65% | 2026-03-31 |
| 7 | GROUP ONE TRADING LLC Custodian | $66.96K | 0.98% | 2026-03-31 |
Insider Activity
Latest: 2026-06-12
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Sell (S) | −25,000 | $21.00 | -$525.0K | EDGAR |
| 2026-06-12 | JOHN E KAO | Chief Executive Officer | Sell (S) | −298,000 | $20.36 | -$6.07M | EDGAR |
| 2026-06-09 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Award (A) | +122,807 | — | EDGAR | |
| 2026-06-09 | Mark D. Kent | President - MSO | Award (A) | +87,719 | — | EDGAR | |
| 2026-06-02 | Mark D. Kent | President - MSO | Buy (P) | +14,848 | $13.31 | $197.6K | EDGAR |
| 2026-05-19 | Dawn Christine Maroney | President | Mixed | −51,500 | $16.09 | -$482.6K | EDGAR |
| 2026-05-13 | JOHN E KAO | Chief Executive Officer | Sell (S) | −298,000 | $16.89 | -$5.03M | EDGAR |
| 2026-04-15 | Dawn Christine Maroney | President | Sell (S) | −30,000 | $20.87 | -$626.2K | EDGAR |
| 2026-04-13 | JOHN E KAO | Chief Executive Officer | Sell (S) | −298,000 | $20.68 | -$6.16M | EDGAR |
| 2026-04-08 | James M Head | Chief Financial Officer | Sell (S) | −11,100 | $21.08 | -$234.0K | EDGAR |
| 2026-04-08 | JOHN E KAO | Chief Executive Officer | Sell (S) | −250,000 | $21.01 | -$5.25M | EDGAR |
| 2026-04-01 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | Sell (S) | −18,013 | $17.79 | -$320.5K | EDGAR |
| 2026-03-23 | JOHN E KAO | Chief Executive Officer | Sell (S) | −118,000 | $17.48 | -$2.06M | EDGAR |
| 2026-03-19 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | Sell (S) | −25,125 | $17.84 | -$448.2K | EDGAR |
| 2026-03-19 | Dawn Christine Maroney | President | Sell (S) | −36,749 | $17.84 | -$655.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
40 insiders · @ $20.60
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | GAP COINVESTMENTS IV, LLC | Director | 61,302,175 | $1.26B | -$1.26B | 2 | 2025-03-17 |
| 2 | GENERAL ATLANTIC GENPAR, L.P. | Director | 60,993,323 | $1.26B | -$1.02B | 1 | 2022-09-20 |
| 3 | General Atlantic (SPV) GP, LLC | Director | 30,842,175 | $635.35M | -$4.75B | 2 | 2025-09-16 |
| 4 | Warburg Pincus Private Equity XII-E, L.P. | Director | 25,519,345 | $525.70M | -$210.66M | 1 | 2021-04-01 |
| 5 | General Atlantic Partners 95, L.P. | Director | 24,596,079 | $506.68M | -$1000.00M | 1 | 2025-09-19 |
| 6 | PINCUS & CO. WARBURG | Director | 20,648,785 | $425.36M | -$225.47M | 2 | 2022-08-16 |
| 7 | WP Global LLC | Director | 20,648,785 | $425.36M | -$463.20M | 2 | 2022-08-16 |
| 8 | Warburg Pincus XII Partners, L.P. | Director | 19,966,785 | $411.32M | -$514.68M | 2 | 2022-08-24 |
| 9 | Warburg Pincus Partners II Holdings, L.P. | Director | 17,922,779 | $369.21M | -$121.30M | 2 | 2022-09-20 |
| 10 | WARBURG PINCUS LLC | Director | 17,922,779 | $369.21M | -$398.01M | 3 | 2022-09-20 |
| 11 | General Atlantic (ALN HLTH), L.P. | Director | 13,476,585 | $277.62M | -$1.25B | 11 | 2025-12-12 |
| 12 | GAP Coinvestments CDA, L.P. | Director | 13,476,585 | $277.62M | -$2.06B | 2 | 2025-12-12 |
| 13 | JOHN E KAO | Chief Executive Officer | 2,995,509 | $61.71M | -$124.55M | 55 | 2026-06-12 |
| 14 | Donald Steven Furman | Chief Clinical Officer | 1,826,538 | $37.63M | -$2.04M | 2 | 2022-04-01 |
| 15 | Robert Thomas Freeman | Chief Financial Officer | 1,557,348 | $32.08M | -$19.76M | 36 | 2025-03-28 |
| 16 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | 1,178,816 | $24.28M | -$3.32M | 23 | 2026-06-12 |
| 17 | Michael Curtis Foster | Chief Legal Officer | 1,132,692 | $23.33M | -$855.7K | 1 | 2021-04-08 |
| 18 | Dinesh M. Kumar | Chief Med & Operating Officer | 1,088,651 | $22.43M | -$7.51M | 25 | 2023-03-31 |
| 19 | Dawn Christine Maroney | President | 977,313 | $20.13M | -$45.27M | 61 | 2026-05-19 |
| 20 | Hakan Kardes | Chief Experience Officer | 678,987 | $13.99M | -$3.91M | 14 | 2025-03-28 |
| 21 | JEFFREY H MARGOLIS | Director | 517,984 | $10.67M | -$336.1K | 14 | 2024-08-16 |
| 22 | Robert L. Scavo | Chief Information Officer | 487,685 | $10.05M | -$4.78M | 13 | 2026-03-19 |
| 23 | Richard A. Cross | SVP, General Counsel | 393,460 | $8.11M | -$63.1K | 5 | 2023-03-31 |
| 24 | Mark B. McClellan | Director | 370,531 | $7.63M | -$354.5K | 7 | 2026-03-17 |
| 25 | Hyong Kim | Chief Medical Officer | 367,701 | $7.57M | -$5.64M | 18 | 2026-03-19 |
| 26 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | 305,451 | $6.29M | -$5.05M | 24 | 2026-04-01 |
| 27 | JACQUELINE B KOSECOFF | Director | 303,963 | $6.26M | $0 | 7 | 2026-03-17 |
| 28 | Sebastian Burzacchi | COO - Mgmt Services Org | 258,630 | $5.33M | -$722.5K | 8 | 2026-03-19 |
| 29 | Melinda Michele Kimbro | Chief People Officer | 175,439 | $3.61M | $0 | 1 | 2023-07-07 |
| 30 | James M Head | Chief Financial Officer | 173,495 | $3.57M | -$234.0K | 3 | 2026-04-08 |
| 31 | DAVID C HODGSON | Director | 173,408 | $3.57M | $0 | 6 | 2026-03-17 |
| 32 | Nicholas Robbert Vorhoff | Director | 173,408 | $3.57M | $0 | 6 | 2026-03-17 |
| 33 | Rajesh Shrestha | Pres., New Markets & CBO | 170,220 | $3.51M | -$159.0K | 1 | 2022-04-01 |
| 34 | Andreas P. Wagner | Chief Human Resources Officer | 160,230 | $3.30M | -$2.19M | 11 | 2026-03-19 |
| 35 | Margaret M McCarthy | Director | 144,441 | $2.98M | $0 | 8 | 2026-03-17 |
| 36 | JODY L BILNEY | Director | 129,267 | $2.66M | $0 | 7 | 2026-03-17 |
| 37 | THOMAS J. CARELLA | Director | 124,478 | $2.56M | $0 | 3 | 2024-03-15 |
| 38 | YON JORDEN | Director | 105,830 | $2.18M | $0 | 7 | 2026-03-17 |
| 39 | Mark D. Kent | President - MSO | 102,567 | $2.11M | $197.6K | 2 | 2026-06-09 |
| 40 | Adnan R. Mansour | Chief Digital Officer | 48,456 | $998.2K | $0 | 2 | 2026-03-17 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 146.1 |
| P/B Ratio | 19.8 |
| P/S Ratio | 1.0 |
| EV/EBITDA | 175.7 |
| TTM Revenue | $4.2B |
| TTM Net Income | $0.0B |
| TTM EPS | $0.14 |
| ROE | 9.6% |
| Debt/Equity | 1.56 |